January 17, 2026
JPM Healthcare opening day triggers more biotech 8-K filings than any other day of the year. Analysis of SEC filing patterns shows 23% of public biotechs tracked by RxDataLab disclose on a single day.
Competitive Intel from What Biotech Does, Not What It Says
Biotech intelligence platform and research services for investors. Aggregated data from trials, filings, patents, and markets—organized to surface operational signals traditional analysis misses.
Clinical Trial Intelligence Platform
Track biotech pipelines, trial changes, and market movements in one place. Company-first organization, automatic change detection, and your research notes connected to live data from trials, filings, and markets.
Explore the Platform →
Recent Analysis
View allDecember 15, 2025
Eight Wave Life Sciences executives adopted 10b5-1 trading plans in two clusters months apart, and all eight plans executed on the day of a clinical trial announcement.
September 15, 2025
How we use embeddings of clinical trial features to visualize and analyze the competitive biotech landscape.
Biotech intelligence built for analysts and agile teams
RxDataLab provides a data platform and specialized intelligence services for biotech investors. We aggregate public data from clinical trial registries, regulatory filings, patent databases, and financial markets into company-centric views that surface operational signals. This combines systematic data infrastructure with domain expertise in neuroscience to assess what companies are actually doing, what’s likely next, and what investors should watch.
Ready to Talk?
Whether you're evaluating an investment opportunity, conducting due diligence, preparing for fundraising, or tracking competitive intelligence, We can provide the data and technical depth you need.
Get in Touch
Or email directly at
[email protected]